For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Sales | 0 | - | - | 0 |
| Service revenue | 25,000 | 37,500 | - | - |
| Cost of revenues | 0 | 0 | - | 2 |
| Gross profit | 25,000 | 37,500 | - | -2 |
| General and administrative | 30,885 | 40,620 | 32,277 | 25,053.5 |
| Total operating expenses | 30,885 | 40,620 | 32,277 | 25,053.5 |
| Operation income | -5,885 | -3,120 | -32,277 | -25,056.5 |
| Interest expense | 2,100 | 2,100 | 2,100 | 2,100 |
| Loss before income taxes | - | - | -34,377 | -32,874.5 |
| Income tax provision | 0 | - | - | - |
| Net loss | -7,985 | -5,220 | -34,377 | -29,256.5 |
| Diluted eps | - | - | 0 | 0 |
| Weighted average number of shares outstanding - basic and diluted | 96,433,333 | 96,433,333 | 99,000,000 | 24,750,000 |
GOLDENWELL BIOTECH, INC. (GWLL)
GOLDENWELL BIOTECH, INC. (GWLL)